Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 8 (2011), Issue 9 (September)

1. Employing a youth-led adult-guided framework: "Why Drive High?" social marketing campaign.
   Fam Community Health, 34(4): 319-30. [Abstract] [Full-text]
2. Environmental risk factors and their impact on the age of onset of schizophrenia: Comparing familial to non-familial schizophrenia.
   Nord J Psychiatry. [Abstract] [Full-text]
3. Antagonist-elicited cannabis withdrawal in humans.
   J Clin Psychopharmacol, 31(5): 603-12. [Abstract] [Full-text]
4. Alcohol and substance use by patients with psychosis presenting to an emergency department: changing patterns.
   Australas Psychiatry, 19(4): 354-9. [Abstract] [Full-text]
5. The association between early conduct problems and early marijuana use in college students.
   J Child Adolesc Subst Abuse, 20(3): 221-236. [Abstract] [Full-text]
6. Forward-Thinking Teens: The Effects of College Costs on Adolescent Risky Behavior.
   Econ Educ Rev, 30(5): 813-825. [Abstract] [Full-text]
7. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.
   South Med J, 104(9): 659-64. [Abstract] [Full-text]
8. Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment.
   Psychiatr Serv, 62(9): 1007-12. [Abstract] [Full-text]
9. Psychosis and smoking cessation: Difficulties in quitting associated with sex and substance abuse.
   Psychiatry Res. [Abstract] [Full-text]
10. Reproductive health characteristics of marijuana and cocaine users: results from the 2002 National Survey of Family Growth.
    Perspect Sex Reprod Health, 43(3): 164-72. [Abstract] [Full-text]
11. Cannabis profiling based on its elemental composition--is it possible?
    J Forensic Sci, 56(5): 1250-5. [Abstract] [Full-text]
12. Self-harm and attempted suicide among therapeutic community admissions.
    Drug Alcohol Rev. [Abstract] [Full-text]
13. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
    Acta Psychiatr Scand. [Abstract] [Full-text]
14. Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use.
    J Neurochem, 118(6): 1101-12. [Abstract] [Full-text]
15. Field testing of collection cards for Cannabis sativa samples with a single hexanucleotide DNA marker.
    J Forensic Sci, 56(5): 1245-9. [Abstract] [Full-text]
16. Characterization of South African adolescents with alcohol use disorders but without psychiatric or polysubstance comorbidity.
    Alcohol Clin Exp Res, 35(9): 1705-15. [Abstract] [Full-text]
17. Canada: psychosis in the immigrant Caribbean population.
    Int J Soc Psychiatry, 57(5): 462-70. [Abstract] [Full-text]
18. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability.
    J Psychopharmacol. [Abstract] [Full-text]
19. Lignin variability in plant cell walls: contribution of new models.
    Plant Sci, 181(4): 379-86. [Abstract] [Full-text]
20. Expression and localization of cannabinoid receptors in human immature oocytes and unfertilized metaphase-II oocytes.
    Reprod Biomed Online, 23(3): 372-9. [Abstract] [Full-text]
21. Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use.
    Drug Alcohol Depend, 118(1): 62-7. [Abstract] [Full-text]
22. A comparative study on the concentrations of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in head and pubic hair.
    Forensic Sci Int, 212(1): 238-41. [Abstract] [Full-text]
23. Estimating equivalent cutoff thresholds for drugs in blood and oral fluid using prevalence regression: a study of tetrahydrocannabinol and amphetamine.
    Forensic Sci Int, 212(1): e26-30. [Abstract] [Full-text]
24. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).
    Forensic Sci Int, 212(1): 247-51. [Abstract] [Full-text]
25. Cannabinoids in oral fluid following passive exposure to marijuana smoke.
    Forensic Sci Int, 212(1): 227-30. [Abstract] [Full-text]
26. Factors determining yield and quality of illicit indoor cannabis (Cannabis spp.) production.
    Forensic Sci Int, 212(1): 158-63. [Abstract] [Full-text]
27. The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory.
    Hum Psychopharmacol. [Abstract] [Full-text]
28. Religious participation and risky health behaviors among adolescents.
    Health Econ, 20(10): 1226-40. [Abstract] [Full-text]
29. The age at onset of psychosis and tobacco use: a systematic meta-analysis.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
30. Adolescent risk behaviours and mealtime routines: does family meal frequency alter the association between family structure and risk behaviour?
    Health Educ Res. [Abstract] [Full-text]
31. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Psychol Med. [Abstract] [Full-text]
32. Cannabis use amongst patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol, 23(10): 891-6. [Abstract] [Full-text]
33. Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia.
    Br J Psychiatry. [Abstract] [Full-text]
34. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
    Eur J Clin Pharmacol, 67(10): 1053-9. [Abstract] [Full-text]
35. Diagnostic characteristics of inpatients in a Western African psychiatric hospital.
    World J Biol Psychiatry, 12: 85-8. [Abstract] [Full-text]
36. Phenotypically Continuous With Clinical Psychosis, Discontinuous in Need for Care: Evidence for an Extended Psychosis Phenotype.
    Schizophr Bull. [Abstract] [Full-text]
37. Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males.
    Drug Alcohol Depend. [Abstract] [Full-text]
38. An analysis of drug-related offenses in Japan: focusing on a discussion of future preventive measures.
    J Forensic Leg Med, 18(7): 317-9. [Abstract] [Full-text]
39. School-related predictors of smoking, drinking and drug use: Evidence from the Belfast Youth Development Study.
    J Adolesc. [Abstract] [Full-text]
40. Adolescent romantic couples influence on substance use in young adulthood.
    J Adolesc. [Abstract] [Full-text]
41. School achievement in 14-year-old youths prenatally exposed to marijuana.
    Neurotoxicol Teratol. [Abstract] [Full-text]
42. Pubertal timing and substance use in middle adolescence: a 2-year follow-up study.
    J Youth Adolesc, 40(10): 1288-301. [Abstract] [Full-text]
43. Performance of Three Point-of-care Urinalysis Test Devices for Drugs of Abuse and Therapeutic Drugs Applied in the Emergency Department.
    J Emerg Med. [Abstract] [Full-text]
44. Exploring racial/ethnic differences in substance use: a preliminary theory-based investigation with juvenile justice-involved youth.
    BMC Pediatr, 11: 71. [Abstract] [Full-text]
45. Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury.
    Neurotox Res. [Abstract] [Full-text]
46. Seven-Year Patterns in US Cigar Use Epidemiology Among Young Adults Aged 18-25 Years: A Focus on Race/Ethnicity and Brand.
    Am J Public Health, 101(10): 1955-62. [Abstract] [Full-text]
47. Substance use and exercise participation among young adults: parallel trajectories in a national cohort-sequential study.
    Addiction, 106(10): 1855-65; discussion 1866-7. [Abstract] [Full-text]
48. The social norms of birth cohorts and adolescent marijuana use in the United States, 1976-2007.
    Addiction, 106(10): 1790-800. [Abstract] [Full-text]
49. Genes and Pathways Co-associated with the Exposure to Multiple Drugs of Abuse, Including Alcohol, Amphetamine/Methamphetamine, Cocaine, Marijuana, Morphine, and/or Nicotine: a Review of Proteomics Analyses.
    Mol Neurobiol. [Abstract] [Full-text]
50. Characterizing smoking topography of cannabis in heavy users.
    Psychopharmacology (Berl). [Abstract] [Full-text]
51. Neuropsychological deficits associated with cannabis use in young adults.
    Drug Alcohol Depend. [Abstract] [Full-text]
52. High peer popularity longitudinally predicts adolescent health risk behavior, or does it?: an examination of linear and quadratic associations.
    J Pediatr Psychol, 36(9): 980-90. [Abstract] [Full-text]
53. Neurocognitive impact of substance use in HIV infection.
    J Acquir Immune Defic Syndr, 58(2): 154-62. [Abstract] [Full-text]
54. Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?
    J Psychopharmacol. [Abstract] [Full-text]
55. Early onset problem behaviors and alcohol, tobacco, and other substance use disorders in young adulthood.
    Drug Alcohol Depend. [Abstract] [Full-text]
56. Drunk versus drugged: How different are the drivers?
    Drug Alcohol Depend. [Abstract] [Full-text]
57. Prevalence and patterns of commonly abused psychoactive prescription drugs in a sample of university students from Lebanon: An opportunity for cross-cultural comparisons.
    Drug Alcohol Depend. [Abstract] [Full-text]
58. Is the Continuity of Externalizing Psychopathology the Same in Adolescents and Middle-Aged Adults? A Test of the Externalizing Spectrum's Developmental Coherence.
    J Abnorm Child Psychol. [Abstract] [Full-text]
59. Oral health and social and emotional well-being in a birth cohort of Aboriginal Australian young adults.
    BMC Public Health, 11: 656. [Abstract] [Full-text]
60. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
    J Pharmacol Exp Ther, 339(1): 173-85. [Abstract] [Full-text]
61. Randomized controlled trial of motivational enhancement therapy with nontreatment-seeking adolescent cannabis users: A further test of the teen marijuana check-up.
    Psychol Addict Behav, 25(3): 474-84. [Abstract] [Full-text]
62. Motives for cannabis use in high-risk adolescent users.
    Psychol Addict Behav, 25(3): 492-500. [Abstract] [Full-text]
63. Posttraumatic stress disorder and cannabis use in a nationally representative sample.
    Psychol Addict Behav, 25(3): 554-8. [Abstract] [Full-text]
64. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
    Psychol Addict Behav, 25(3): 485-91. [Abstract] [Full-text]
65. Bilateral testicular self-castration due to cannabis abuse: a case report.
    J Med Case Reports, 5(1): 404. [Abstract] [Full-text]
66. Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases.
    Drug Metab Dispos, 39(10): 1967-76. [Abstract] [Full-text]
67. The business cycle and drug use in Australia: Evidence from repeated cross-sections of individual level data.
    Int J Drug Policy, 22(5): 341-52. [Abstract] [Full-text]
68. Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions.
    Appl Biochem Biotechnol. [Abstract] [Full-text]
69. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents.
    Psychopharmacology (Berl). [Abstract] [Full-text]
70. The genetic basis of the endocannabinoid system and drug addiction in humans.
    J Psychopharmacol. [Abstract] [Full-text]
71. Motivational and mindfulness intervention for young adult female marijuana users.
    J Subst Abuse Treat. [Abstract] [Full-text]
72. Synthetic cannabinoid use: a case series of adolescents.
    J Adolesc Health, 49(4): 347-9. [Abstract] [Full-text]
73. A LONGITUDINAL STUDY OF SUBSTANCE USE AND VIOLENT VICTIMIZATION IN ADULTHOOD AMONG A COHORT OF URBAN AFRICAN AMERICANS.
    Addiction. [Abstract] [Full-text]
74. Cocaine use trajectories of club drug-using young adults recruited using time-space sampling.
    Addict Behav, 36(12): 1292-300. [Abstract] [Full-text]
75. Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa).
    J Nat Prod, 74(9): 2019-2022. [Abstract] [Full-text]
76. Prevalence and characteristics of substance abuse treatment utilization by US adolescents: National data from 1987 to 2008.
    Addict Behav, 36(12): 1349-52. [Abstract] [Full-text]
77. Social network influences of alcohol and marijuana cognitive associations.
    Addict Behav, 36(12): 1305-8. [Abstract] [Full-text]
78. Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City.
    Addict Behav, 36(12): 1282-7. [Abstract] [Full-text]
79. Reward sensitivity and outcome expectancies as predictors of ecstasy use in young adults.
    Addict Behav, 36(12): 1337-40. [Abstract] [Full-text]
80. Characteristics associated with smoking in a Hispanic college student sample.
    Addict Behav, 36(12): 1329-32. [Abstract] [Full-text]
81. Patterns of use, sequence of onsets and correlates of tobacco and cannabis.
    Addict Behav, 36(12): 1141-7. [Abstract] [Full-text]
82. Cannabis, COMT and psychotic experiences.
    Br J Psychiatry. [Abstract] [Full-text]
83. Immediate antecedents of marijuana use: An analysis from ecological momentary assessment.
    J Behav Ther Exp Psychiatry, 43(1): 647-655. [Abstract] [Full-text]
84. Psychological, peer, and family influences on smoking among an adolescent psychiatric sample.
    J Subst Abuse Treat. [Abstract] [Full-text]
85. A school-based resilience intervention to decrease tobacco, alcohol and marijuana use in high school students.
    BMC Public Health, 11(1): 722. [Abstract] [Full-text]
86. Relationships between hours of sleep and health-risk behaviors in US adolescent students.
    Prev Med. [Abstract] [Full-text]
87. Effects of endocannabinoid system modulation on cognitive and emotional behavior.
    Front Behav Neurosci, 5: 57. [Abstract] [Full-text]
88. ∆(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.
    Psychopharmacology (Berl), 217(4): 485-94. [Abstract] [Full-text]
89. Cannabis use and psychosis: re-visiting the role of childhood trauma.
    Psychol Med, 41(11): 2339-48. [Abstract] [Full-text]
90. Evidence for a persistent, environment-dependent and deteriorating subtype of subclinical psychotic experiences: a 6-year longitudinal general population study.
    Psychol Med, 41(11): 2317-29. [Abstract] [Full-text]
91. Cerebellar white-matter changes in cannabis users with and without schizophrenia.
    Psychol Med, 41(11): 2349-59. [Abstract] [Full-text]
92. Fluid intelligence and psychosocial outcome: from logical problem solving to social adaptation.
    PLoS One, 6(9): e24858. [Abstract] [Full-text]
93. Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making.
    Neuropsychopharmacology. [Abstract] [Full-text]
94. Quantifying cannabis use with the Timeline Followback approach: A psychometric evaluation.
    Drug Alcohol Depend. [Abstract] [Full-text]
95. Tobacco, alcohol, cannabis and other illegal drug use among young adults: The socioeconomic context.
    Drug Alcohol Depend. [Abstract] [Full-text]
96. Corpus callosum size and shape alterations in adolescent inhalant users.
    Addict Biol. [Abstract] [Full-text]
97. A damage/benefit evaluation of addictive product use.
    Addiction. [Abstract] [Full-text]
98. Evidence of increasing age of onset of cannabis use among younger Australians.
    Addiction. [Abstract] [Full-text]
99. Developing the climate schools: alcohol and cannabis module: a harm-minimization, universal drug prevention program facilitated by the internet.
    Subst Use Misuse, 46(13): 1651-63. [Abstract] [Full-text]
100. Influence of risk and protective factors on substance use outcomes across developmental periods: a comparison of youth and young adults.
     Subst Use Misuse, 46(13): 1604-12. [Abstract] [Full-text]
101. Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration.
     Clin Chem, 57(10): 1406-14. [Abstract] [Full-text]
102. Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference.
     Pharmacol Biochem Behav, 100(1): 33-9. [Abstract] [Full-text]
103. Caregiver and self-report of mental health symptoms in 9-year old children with prenatal cocaine exposure.
     Neurotoxicol Teratol, 33(5): 582-91. [Abstract] [Full-text]
104. Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users.
     Allergol Immunopathol (Madr), 39(5): 271-9. [Abstract] [Full-text]
105. A descriptive survey of types, spread and characteristics of substance abuse treatment centers in Nigeria.
     Subst Abuse Treat Prev Policy, 6: 25. [Abstract] [Full-text]
106. Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence.
     J Clin Exp Neuropsychol, 33(7): 735-52. [Abstract] [Full-text]
107. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
     Drug Test Anal, 3(9): 609-20. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.